Powder bed 3D-printing of highly loaded drug delivery devices with hydroxypropyl cellulose as solid binder

[Display omitted] 3D-printing is a promising tool to pave the way to the widespread adaption of individualized medicine. Several printing techniques have been investigated and introduced to pharmaceutical research. Until now, only one 3D-printed medicine is approved on the US market. The medicine is...

Full description

Saved in:
Bibliographic Details
Published in:International journal of pharmaceutics Vol. 555; pp. 198 - 206
Main Authors: Infanger, Sophia, Haemmerli, Alexander, Iliev, Simona, Baier, Andrea, Stoyanov, Edmont, Quodbach, Julian
Format: Journal Article
Language:English
Published: Netherlands Elsevier B.V 30-01-2019
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract [Display omitted] 3D-printing is a promising tool to pave the way to the widespread adaption of individualized medicine. Several printing techniques have been investigated and introduced to pharmaceutical research. Until now, only one 3D-printed medicine is approved on the US market. The medicine is manufactured via drop-on-powder deposition, which uses inkjet printing to jet a liquid binder on a powder bed to create 3D objects. However, inkjet processes are prone to nozzle clogging when binders or active pharmaceutical ingredients (APIs) are included in the printing ink. This renders the formulation development of the ink the most challenging step. In this study, different hydroxypropyl cellulose (HPC) grades were investigated as solid binders in the powder formulation on a commercially available DoP printer. The printed ink only consisted of a water/ethanol mixture. Formulations containing 70% caffeine as model API were developed and tablets printed. It was found that the friability of the tablets greatly depends on the particle size of the employed binder, whereas disintegration time and dissolution properties mainly depend on the viscosity of the employed binders. Higher viscous binders led to slower disintegration and dissolution whereas lower viscous binders led to faster disintegration and dissolution. The study demonstrates that HPC is a suitable solid binder for DoP printing and that 3D-DoP printing can be used to print robust dosage forms.
AbstractList 3D-printing is a promising tool to pave the way to the widespread adaption of individualized medicine. Several printing techniques have been investigated and introduced to pharmaceutical research. Until now, only one 3D-printed medicine is approved on the US market. The medicine is manufactured via drop-on-powder deposition, which uses inkjet printing to jet a liquid binder on a powder bed to create 3D objects. However, inkjet processes are prone to nozzle clogging when binders or active pharmaceutical ingredients (APIs) are included in the printing ink. This renders the formulation development of the ink the most challenging step. In this study, different hydroxypropyl cellulose (HPC) grades were investigated as solid binders in the powder formulation on a commercially available DoP printer. The printed ink only consisted of a water/ethanol mixture. Formulations containing 70% caffeine as model API were developed and tablets printed. It was found that the friability of the tablets greatly depends on the particle size of the employed binder, whereas disintegration time and dissolution properties mainly depend on the viscosity of the employed binders. Higher viscous binders led to slower disintegration and dissolution whereas lower viscous binders led to faster disintegration and dissolution. The study demonstrates that HPC is a suitable solid binder for DoP printing and that 3D-DoP printing can be used to print robust dosage forms.
[Display omitted] 3D-printing is a promising tool to pave the way to the widespread adaption of individualized medicine. Several printing techniques have been investigated and introduced to pharmaceutical research. Until now, only one 3D-printed medicine is approved on the US market. The medicine is manufactured via drop-on-powder deposition, which uses inkjet printing to jet a liquid binder on a powder bed to create 3D objects. However, inkjet processes are prone to nozzle clogging when binders or active pharmaceutical ingredients (APIs) are included in the printing ink. This renders the formulation development of the ink the most challenging step. In this study, different hydroxypropyl cellulose (HPC) grades were investigated as solid binders in the powder formulation on a commercially available DoP printer. The printed ink only consisted of a water/ethanol mixture. Formulations containing 70% caffeine as model API were developed and tablets printed. It was found that the friability of the tablets greatly depends on the particle size of the employed binder, whereas disintegration time and dissolution properties mainly depend on the viscosity of the employed binders. Higher viscous binders led to slower disintegration and dissolution whereas lower viscous binders led to faster disintegration and dissolution. The study demonstrates that HPC is a suitable solid binder for DoP printing and that 3D-DoP printing can be used to print robust dosage forms.
Author Baier, Andrea
Infanger, Sophia
Haemmerli, Alexander
Iliev, Simona
Stoyanov, Edmont
Quodbach, Julian
Author_xml – sequence: 1
  givenname: Sophia
  surname: Infanger
  fullname: Infanger, Sophia
  organization: Life Sciences and Facility Management, Zurich University of Applied Sciences, Einsiedlerstrasse 31, 8820 Waedenswil, Switzerland
– sequence: 2
  givenname: Alexander
  surname: Haemmerli
  fullname: Haemmerli, Alexander
  organization: Life Sciences and Facility Management, Zurich University of Applied Sciences, Einsiedlerstrasse 31, 8820 Waedenswil, Switzerland
– sequence: 3
  givenname: Simona
  surname: Iliev
  fullname: Iliev, Simona
  organization: Life Sciences and Facility Management, Zurich University of Applied Sciences, Einsiedlerstrasse 31, 8820 Waedenswil, Switzerland
– sequence: 4
  givenname: Andrea
  surname: Baier
  fullname: Baier, Andrea
  organization: Life Sciences and Facility Management, Zurich University of Applied Sciences, Einsiedlerstrasse 31, 8820 Waedenswil, Switzerland
– sequence: 5
  givenname: Edmont
  surname: Stoyanov
  fullname: Stoyanov, Edmont
  organization: Nisso Chemical Europe GmbH, Berliner Allee 42, 40212 Duesseldorf, Germany
– sequence: 6
  givenname: Julian
  orcidid: 0000-0003-2471-4502
  surname: Quodbach
  fullname: Quodbach, Julian
  email: julian.quodbach@hhu.de
  organization: Institute of Pharmaceutics and Biopharmaceutics, Heinrich Heine University Duesseldorf, Universitaetsstrasse 1, 40225 Duesseldorf, Germany
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30458260$$D View this record in MEDLINE/PubMed
BookMark eNqFkM1u1DAUhS1URKeFRwB5ySbBjuOfWSHUAkWqBIvuLce-mTjyxIOdTJu3x6MZ2LLylXzuPed8N-hqihMg9J6SmhIqPo21Hw-DSfu6IVTVlNakVa_QhirJKtZKcYU2hElVcSrZNbrJeSSEiIayN-iakZarRpANGn_FZwcJd-Awu68OyU-zn3Y49njwuyGsOETjyqdLyw47CP4IaS3D0VvI-NnPAx5Wl-LLekjxsAZsIYQlxAzYZJxj8A53fioeb9Hr3oQM7y7vLXr69vXp7qF6_Pn9x92Xx8qyLZ0rSlu1NVy0XWdMxxV3JfXWKG4sVaUCsZQ1ojOiN1vSSymIU0aVYkZKU-rdoo_nsyXP7wXyrPc-n0KZCeKSdZEIzpuWySLlZ6lNMecEvS799yatmhJ9oqxHfaGsT5Q1pbpQLnsfLhZLtwf3b-sv1iL4fBZA6Xn0kHS2HiYLziews3bR_8fiDwVtkxU
CitedBy_id crossref_primary_10_3390_pharmaceutics13081212
crossref_primary_10_2174_1567201821666230915150544
crossref_primary_10_1016_j_pmatsci_2020_100684
crossref_primary_10_1016_j_ijpharm_2022_121555
crossref_primary_10_3390_pharmaceutics12020124
crossref_primary_10_1016_j_ajps_2021_02_003
crossref_primary_10_1208_s12249_020_01905_8
crossref_primary_10_3390_pharmaceutics14102179
crossref_primary_10_1016_j_addma_2019_101025
crossref_primary_10_55971_EJLS_1181158
crossref_primary_10_1016_j_ejps_2022_106280
crossref_primary_10_1016_j_ijpx_2022_100151
crossref_primary_10_1016_j_addr_2021_05_003
crossref_primary_10_1016_j_foodchem_2024_140348
crossref_primary_10_1615_CritRevTherDrugCarrierSyst_2023046832
crossref_primary_10_1088_1748_605X_ad2a3a
crossref_primary_10_1016_j_xphs_2020_06_027
crossref_primary_10_3390_pharmaceutics15020395
crossref_primary_10_3390_pharmaceutics15041152
crossref_primary_10_1016_j_ajps_2020_06_003
crossref_primary_10_22159_ajpcr_2022_v15i8_45136
crossref_primary_10_1016_j_addr_2021_113943
crossref_primary_10_1016_j_xphs_2021_08_030
crossref_primary_10_1208_s12249_022_02321_w
crossref_primary_10_1016_j_ejpb_2023_11_023
crossref_primary_10_1002_VIW_20200126
crossref_primary_10_1039_D0RA03620J
crossref_primary_10_1016_j_jphotobiol_2021_112201
crossref_primary_10_3390_ma13214961
crossref_primary_10_1016_j_ijpharm_2021_120330
crossref_primary_10_1016_j_jconrel_2021_02_027
crossref_primary_10_1080_17425247_2021_2011856
crossref_primary_10_3390_pharmaceutics11040150
crossref_primary_10_2174_1381612825666190507115504
crossref_primary_10_3390_pharmaceutics14112320
crossref_primary_10_1007_s40964_020_00127_5
crossref_primary_10_1016_j_apsb_2021_03_015
crossref_primary_10_3390_pharmaceutics15092193
crossref_primary_10_1111_bcpt_13974
crossref_primary_10_3390_pharmaceutics14081568
crossref_primary_10_1016_j_ijpharm_2020_119653
crossref_primary_10_1039_D1QM00390A
crossref_primary_10_1021_acsnano_3c11432
crossref_primary_10_1016_j_ijpharm_2022_122066
crossref_primary_10_1016_j_ijpx_2023_100179
crossref_primary_10_1016_j_jconrel_2022_09_023
crossref_primary_10_1016_j_ijpharm_2022_122540
crossref_primary_10_1007_s11095_021_03041_9
crossref_primary_10_1016_j_apsb_2021_05_014
crossref_primary_10_1016_j_ijpx_2024_100256
crossref_primary_10_3390_molecules27092784
crossref_primary_10_1016_j_powtec_2021_05_050
crossref_primary_10_1080_01932691_2023_2289623
crossref_primary_10_1007_s40005_020_00498_5
crossref_primary_10_1016_j_scienta_2023_111884
crossref_primary_10_1016_j_ijpharm_2020_119820
crossref_primary_10_3390_pharmaceutics13030358
crossref_primary_10_3390_compounds4010004
crossref_primary_10_1016_j_addma_2020_101209
crossref_primary_10_1016_j_ijpharm_2023_123506
crossref_primary_10_3390_pharmaceutics14122589
crossref_primary_10_1016_j_xphs_2022_08_030
crossref_primary_10_1016_j_addr_2023_114859
crossref_primary_10_1093_jpp_rgab146
crossref_primary_10_1016_j_ijpharm_2021_120791
crossref_primary_10_3390_pharmaceutics12070620
crossref_primary_10_1016_j_ijpharm_2023_123101
crossref_primary_10_3390_pharmaceutics16030317
crossref_primary_10_1186_s43088_020_00040_4
crossref_primary_10_1016_j_pmatsci_2020_100707
Cites_doi 10.1002/jps.2600501018
10.1056/NEJMp1006304
10.1016/S0168-3659(99)00225-4
10.1002/jps.2600521210
10.1208/s12249-018-1012-5
10.1016/j.ijpharm.2015.12.071
10.1016/j.addr.2018.05.006
10.1016/S0168-3659(99)00224-2
10.1016/j.addr.2016.01.003
10.1016/j.ijpharm.2008.12.008
10.1080/03639040500519300
10.1016/0168-3659(95)00173-5
10.1016/S0928-0987(01)00095-1
10.1248/cpb.22.2346
10.1002/adhm.201800417
10.1007/s11095-011-0450-5
10.1517/17425247.2013.859134
10.1056/NEJMp1500523
ContentType Journal Article
Copyright 2018 Elsevier B.V.
Copyright © 2018 Elsevier B.V. All rights reserved.
Copyright_xml – notice: 2018 Elsevier B.V.
– notice: Copyright © 2018 Elsevier B.V. All rights reserved.
DBID NPM
AAYXX
CITATION
7X8
DOI 10.1016/j.ijpharm.2018.11.048
DatabaseName PubMed
CrossRef
MEDLINE - Academic
DatabaseTitle PubMed
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
PubMed

DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1873-3476
EndPage 206
ExternalDocumentID 10_1016_j_ijpharm_2018_11_048
30458260
S037851731830872X
Genre Journal Article
GroupedDBID ---
--K
--M
.~1
0R~
1B1
1RT
1~.
1~5
4.4
457
4G.
5GY
7-5
71M
8P~
9JM
AABNK
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AATCM
AAXUO
ABFNM
ABFRF
ABJNI
ABMAC
ABOCM
ABYKQ
ABZDS
ACDAQ
ACGFO
ACGFS
ACIUM
ACRLP
ADBBV
ADEZE
AEBSH
AEFWE
AEKER
AENEX
AFKWA
AFTJW
AFXIZ
AGHFR
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJOXV
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
AXJTR
BKOJK
BLXMC
C45
CS3
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FIRID
FNPLU
FYGXN
G-Q
GBLVA
IHE
J1W
KOM
M34
M41
MO0
N9A
O-L
O9-
OAUVE
OGGZJ
OVD
OZT
P-8
P-9
P2P
PC.
Q38
RIG
ROL
RPZ
SCC
SDF
SDG
SDP
SES
SPCBC
SSP
SSZ
T5K
TEORI
~02
~G-
AAQFI
AAXKI
AKRWK
NPM
.GJ
29J
3O-
53G
5VS
AAQXK
AAYXX
ABXDB
ADMUD
AFJKZ
ASPBG
AVWKF
AZFZN
CITATION
FEDTE
FGOYB
G-2
HMT
HVGLF
HZ~
R2-
SEW
SPT
WUQ
ZXP
7X8
ID FETCH-LOGICAL-c391t-11489a564bbaab585d0629a85ac180000c1326ba6fa90f7760d8a8621a77a213
ISSN 0378-5173
IngestDate Fri Oct 25 21:51:12 EDT 2024
Thu Sep 26 16:34:43 EDT 2024
Wed Oct 16 00:51:37 EDT 2024
Fri Feb 23 02:29:54 EST 2024
IsPeerReviewed true
IsScholarly true
Keywords Drop-on-powder
Inkjet
Binder free
Individualized medicine
3D-printing
Drop-on-solid
Language English
License Copyright © 2018 Elsevier B.V. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c391t-11489a564bbaab585d0629a85ac180000c1326ba6fa90f7760d8a8621a77a213
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ORCID 0000-0003-2471-4502
PMID 30458260
PQID 2136552437
PQPubID 23479
PageCount 9
ParticipantIDs proquest_miscellaneous_2136552437
crossref_primary_10_1016_j_ijpharm_2018_11_048
pubmed_primary_30458260
elsevier_sciencedirect_doi_10_1016_j_ijpharm_2018_11_048
PublicationCentury 2000
PublicationDate 2019-01-30
PublicationDateYYYYMMDD 2019-01-30
PublicationDate_xml – month: 01
  year: 2019
  text: 2019-01-30
  day: 30
PublicationDecade 2010
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle International journal of pharmaceutics
PublicationTitleAlternate Int J Pharm
PublicationYear 2019
Publisher Elsevier B.V
Publisher_xml – name: Elsevier B.V
References Arndt, Kleinebudde (b0005) 2017
Machida, Nagai (b0070) 1974; 22
Wu, Borland, Giordano, Cima, Sachs, Cima (b0095) 1996; 40
Costa, Sousa Lobo (b0025) 2001; 13
Hamburg, Collins (b0040) 2010; 363
Katstra, Palazzolo, Rowe, Giritlioglu, Teung, Cima (b0055) 2000; 66
Arndt, Kleinebudde (b0010) 2018
Yu, Yu, Branford-White, Ma, Zhu, Li, Yang (b0100) 2009; 370
Lim, Kathuria, Tan, Kang (b0065) 2018
Higuchi (b0050) 1963; 52
Kolakovic, Viitala, Ihalainen, Genina, Peltonen, Sandler (b0060) 2013; 10
Qi, Craig (b0075) 2016
Wang, Tejwani, Roach, Kay, Yoo, Surprenant, Monkhouse, Pryor (b0090) 2006; 32
Rowe, Katstra, Palazzolo, Giritlioglu, Teung, Cima (b0080) 2000; 66
Buanz, Saunders, Basit, Gaisford (b0015) 2011; 28
Collins, Varmus (b0020) 2015; 372
Goole, Amighi (b0035) 2016; 499
Ghosh, Ning, Wang, Kong (b0030) 2018; 7
Schulze (b0085) 2008
Higuchi (b0045) 1961; 50
Qi (10.1016/j.ijpharm.2018.11.048_b0075) 2016
Buanz (10.1016/j.ijpharm.2018.11.048_b0015) 2011; 28
Schulze (10.1016/j.ijpharm.2018.11.048_b0085) 2008
Hamburg (10.1016/j.ijpharm.2018.11.048_b0040) 2010; 363
Higuchi (10.1016/j.ijpharm.2018.11.048_b0045) 1961; 50
Rowe (10.1016/j.ijpharm.2018.11.048_b0080) 2000; 66
Arndt (10.1016/j.ijpharm.2018.11.048_b0010) 2018
Collins (10.1016/j.ijpharm.2018.11.048_b0020) 2015; 372
Katstra (10.1016/j.ijpharm.2018.11.048_b0055) 2000; 66
Wu (10.1016/j.ijpharm.2018.11.048_b0095) 1996; 40
Kolakovic (10.1016/j.ijpharm.2018.11.048_b0060) 2013; 10
Machida (10.1016/j.ijpharm.2018.11.048_b0070) 1974; 22
Goole (10.1016/j.ijpharm.2018.11.048_b0035) 2016; 499
Lim (10.1016/j.ijpharm.2018.11.048_b0065) 2018
Arndt (10.1016/j.ijpharm.2018.11.048_b0005) 2017
Wang (10.1016/j.ijpharm.2018.11.048_b0090) 2006; 32
Costa (10.1016/j.ijpharm.2018.11.048_b0025) 2001; 13
Higuchi (10.1016/j.ijpharm.2018.11.048_b0050) 1963; 52
Ghosh (10.1016/j.ijpharm.2018.11.048_b0030) 2018; 7
Yu (10.1016/j.ijpharm.2018.11.048_b0100) 2009; 370
References_xml – volume: 13
  start-page: 123
  year: 2001
  end-page: 133
  ident: b0025
  article-title: Modeling and comparison of dissolution profiles
  publication-title: Eur. J. Pharm. Sci.
  contributor:
    fullname: Sousa Lobo
– volume: 499
  start-page: 376
  year: 2016
  end-page: 394
  ident: b0035
  article-title: 3D printing in pharmaceutics: a new tool for designing customized drug delivery systems
  publication-title: Int. J. Pharm.
  contributor:
    fullname: Amighi
– volume: 40
  start-page: 77
  year: 1996
  end-page: 87
  ident: b0095
  article-title: Solid free-form fabrication of drug delivery devices
  publication-title: J. Controlled Release
  contributor:
    fullname: Cima
– volume: 28
  start-page: 2386
  year: 2011
  ident: b0015
  article-title: Preparation of personalized-dose salbutamol sulphate oral films with thermal ink-jet printing
  publication-title: Pharm. Res.
  contributor:
    fullname: Gaisford
– volume: 7
  start-page: 1800417
  year: 2018
  ident: b0030
  article-title: Addressing unmet clinical needs with 3D printing technologies
  publication-title: Adv. Healthc. Mater.
  contributor:
    fullname: Kong
– year: 2017
  ident: b0005
  article-title: Influence of binder properties on dry granules and tablets
  publication-title: Powder Technol.
  contributor:
    fullname: Kleinebudde
– volume: 370
  start-page: 160
  year: 2009
  end-page: 166
  ident: b0100
  article-title: Novel drug delivery devices for providing linear release profiles fabricated by 3DP
  publication-title: Int. J. Pharm.
  contributor:
    fullname: Yang
– volume: 363
  start-page: 301
  year: 2010
  end-page: 304
  ident: b0040
  article-title: The path to personalized medicine
  publication-title: N. Engl. J. Med.
  contributor:
    fullname: Collins
– year: 2008
  ident: b0085
  article-title: Powder and Bulk Solids: Behavior, Characterization, Storage and Flow
  contributor:
    fullname: Schulze
– year: 2018
  ident: b0010
  article-title: Roll Compaction and tableting of high loaded metformin formulations using efficient binders
  publication-title: AAPS PharmSciTech
  contributor:
    fullname: Kleinebudde
– volume: 372
  start-page: 793
  year: 2015
  end-page: 795
  ident: b0020
  article-title: A new initiative on precision medicine
  publication-title: N. Engl. J. Med.
  contributor:
    fullname: Varmus
– year: 2018
  ident: b0065
  article-title: 3D printed drug delivery and testing systems — a passing fad or the future?
  publication-title: Adv. Drug Deliv. Rev.
  contributor:
    fullname: Kang
– year: 2016
  ident: b0075
  article-title: Recent developments in micro- and nanofabrication techniques for the preparation of amorphous pharmaceutical dosage forms
  publication-title: Adv. Drug Deliv. Rev.
  contributor:
    fullname: Craig
– volume: 66
  start-page: 11
  year: 2000
  end-page: 17
  ident: b0080
  article-title: Multimechanism oral dosage forms fabricated by three dimensional printing™
  publication-title: J. Controlled Release
  contributor:
    fullname: Cima
– volume: 22
  start-page: 2346
  year: 1974
  end-page: 2351
  ident: b0070
  article-title: Directly compressed tablets containing hydroxypropyl cellulose in addition to starch or lactose
  publication-title: Chem. Pharm. Bull.
  contributor:
    fullname: Nagai
– volume: 32
  start-page: 367
  year: 2006
  end-page: 376
  ident: b0090
  article-title: Development of near zero-order release dosage forms using three-dimensional printing (3-DP™) technology
  publication-title: Drug Dev. Ind. Pharm.
  contributor:
    fullname: Pryor
– volume: 52
  start-page: 1145
  year: 1963
  end-page: 1149
  ident: b0050
  article-title: Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices
  publication-title: J. Pharm. Sci.
  contributor:
    fullname: Higuchi
– volume: 50
  start-page: 874
  year: 1961
  end-page: 875
  ident: b0045
  article-title: Rate of release of medicaments from ointment bases containing drugs in suspension
  publication-title: J. Pharm. Sci.
  contributor:
    fullname: Higuchi
– volume: 66
  start-page: 1
  year: 2000
  end-page: 9
  ident: b0055
  article-title: Oral dosage forms fabricated by Three Dimensional Printing™
  publication-title: J. Controlled Release
  contributor:
    fullname: Cima
– volume: 10
  start-page: 1711
  year: 2013
  end-page: 1723
  ident: b0060
  article-title: Printing technologies in fabrication of drug delivery systems
  publication-title: Expert Opin. Drug Deliv.
  contributor:
    fullname: Sandler
– volume: 50
  start-page: 874
  year: 1961
  ident: 10.1016/j.ijpharm.2018.11.048_b0045
  article-title: Rate of release of medicaments from ointment bases containing drugs in suspension
  publication-title: J. Pharm. Sci.
  doi: 10.1002/jps.2600501018
  contributor:
    fullname: Higuchi
– volume: 363
  start-page: 301
  year: 2010
  ident: 10.1016/j.ijpharm.2018.11.048_b0040
  article-title: The path to personalized medicine
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMp1006304
  contributor:
    fullname: Hamburg
– volume: 66
  start-page: 1
  year: 2000
  ident: 10.1016/j.ijpharm.2018.11.048_b0055
  article-title: Oral dosage forms fabricated by Three Dimensional Printing™
  publication-title: J. Controlled Release
  doi: 10.1016/S0168-3659(99)00225-4
  contributor:
    fullname: Katstra
– volume: 52
  start-page: 1145
  year: 1963
  ident: 10.1016/j.ijpharm.2018.11.048_b0050
  article-title: Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices
  publication-title: J. Pharm. Sci.
  doi: 10.1002/jps.2600521210
  contributor:
    fullname: Higuchi
– year: 2008
  ident: 10.1016/j.ijpharm.2018.11.048_b0085
  contributor:
    fullname: Schulze
– year: 2018
  ident: 10.1016/j.ijpharm.2018.11.048_b0010
  article-title: Roll Compaction and tableting of high loaded metformin formulations using efficient binders
  publication-title: AAPS PharmSciTech
  doi: 10.1208/s12249-018-1012-5
  contributor:
    fullname: Arndt
– volume: 499
  start-page: 376
  year: 2016
  ident: 10.1016/j.ijpharm.2018.11.048_b0035
  article-title: 3D printing in pharmaceutics: a new tool for designing customized drug delivery systems
  publication-title: Int. J. Pharm.
  doi: 10.1016/j.ijpharm.2015.12.071
  contributor:
    fullname: Goole
– year: 2018
  ident: 10.1016/j.ijpharm.2018.11.048_b0065
  article-title: 3D printed drug delivery and testing systems — a passing fad or the future?
  publication-title: Adv. Drug Deliv. Rev.
  doi: 10.1016/j.addr.2018.05.006
  contributor:
    fullname: Lim
– year: 2017
  ident: 10.1016/j.ijpharm.2018.11.048_b0005
  article-title: Influence of binder properties on dry granules and tablets
  publication-title: Powder Technol.
  contributor:
    fullname: Arndt
– volume: 66
  start-page: 11
  year: 2000
  ident: 10.1016/j.ijpharm.2018.11.048_b0080
  article-title: Multimechanism oral dosage forms fabricated by three dimensional printing™
  publication-title: J. Controlled Release
  doi: 10.1016/S0168-3659(99)00224-2
  contributor:
    fullname: Rowe
– year: 2016
  ident: 10.1016/j.ijpharm.2018.11.048_b0075
  article-title: Recent developments in micro- and nanofabrication techniques for the preparation of amorphous pharmaceutical dosage forms
  publication-title: Adv. Drug Deliv. Rev.
  doi: 10.1016/j.addr.2016.01.003
  contributor:
    fullname: Qi
– volume: 370
  start-page: 160
  year: 2009
  ident: 10.1016/j.ijpharm.2018.11.048_b0100
  article-title: Novel drug delivery devices for providing linear release profiles fabricated by 3DP
  publication-title: Int. J. Pharm.
  doi: 10.1016/j.ijpharm.2008.12.008
  contributor:
    fullname: Yu
– volume: 32
  start-page: 367
  year: 2006
  ident: 10.1016/j.ijpharm.2018.11.048_b0090
  article-title: Development of near zero-order release dosage forms using three-dimensional printing (3-DP™) technology
  publication-title: Drug Dev. Ind. Pharm.
  doi: 10.1080/03639040500519300
  contributor:
    fullname: Wang
– volume: 40
  start-page: 77
  year: 1996
  ident: 10.1016/j.ijpharm.2018.11.048_b0095
  article-title: Solid free-form fabrication of drug delivery devices
  publication-title: J. Controlled Release
  doi: 10.1016/0168-3659(95)00173-5
  contributor:
    fullname: Wu
– volume: 13
  start-page: 123
  year: 2001
  ident: 10.1016/j.ijpharm.2018.11.048_b0025
  article-title: Modeling and comparison of dissolution profiles
  publication-title: Eur. J. Pharm. Sci.
  doi: 10.1016/S0928-0987(01)00095-1
  contributor:
    fullname: Costa
– volume: 22
  start-page: 2346
  year: 1974
  ident: 10.1016/j.ijpharm.2018.11.048_b0070
  article-title: Directly compressed tablets containing hydroxypropyl cellulose in addition to starch or lactose
  publication-title: Chem. Pharm. Bull.
  doi: 10.1248/cpb.22.2346
  contributor:
    fullname: Machida
– volume: 7
  start-page: 1800417
  year: 2018
  ident: 10.1016/j.ijpharm.2018.11.048_b0030
  article-title: Addressing unmet clinical needs with 3D printing technologies
  publication-title: Adv. Healthc. Mater.
  doi: 10.1002/adhm.201800417
  contributor:
    fullname: Ghosh
– volume: 28
  start-page: 2386
  year: 2011
  ident: 10.1016/j.ijpharm.2018.11.048_b0015
  article-title: Preparation of personalized-dose salbutamol sulphate oral films with thermal ink-jet printing
  publication-title: Pharm. Res.
  doi: 10.1007/s11095-011-0450-5
  contributor:
    fullname: Buanz
– volume: 10
  start-page: 1711
  year: 2013
  ident: 10.1016/j.ijpharm.2018.11.048_b0060
  article-title: Printing technologies in fabrication of drug delivery systems
  publication-title: Expert Opin. Drug Deliv.
  doi: 10.1517/17425247.2013.859134
  contributor:
    fullname: Kolakovic
– volume: 372
  start-page: 793
  year: 2015
  ident: 10.1016/j.ijpharm.2018.11.048_b0020
  article-title: A new initiative on precision medicine
  publication-title: N. Engl. J. Med.
  doi: 10.1056/NEJMp1500523
  contributor:
    fullname: Collins
SSID ssj0006213
Score 2.5778794
Snippet [Display omitted] 3D-printing is a promising tool to pave the way to the widespread adaption of individualized medicine. Several printing techniques have been...
3D-printing is a promising tool to pave the way to the widespread adaption of individualized medicine. Several printing techniques have been investigated and...
SourceID proquest
crossref
pubmed
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 198
SubjectTerms 3D-printing
Binder free
Drop-on-powder
Drop-on-solid
Individualized medicine
Inkjet
Title Powder bed 3D-printing of highly loaded drug delivery devices with hydroxypropyl cellulose as solid binder
URI https://dx.doi.org/10.1016/j.ijpharm.2018.11.048
https://www.ncbi.nlm.nih.gov/pubmed/30458260
https://search.proquest.com/docview/2136552437
Volume 555
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1La9tAEF6c5NJL6bvuiy2UXBy5eq20OobGJemhGOKDb2L0qm2EZKyoRf--M9rVI6ShD-hFmLVXWvb7PDszmgdjH0Akph35wvAygQZKHEsjShPHMOPEl2AGJkSUjXx57X9dy4uFu5hMumY6w9h_RRrHEGvKnP0LtPub4gB-Rszxiqjj9Y9wX5Y_qDwEbsXMuTDIbdcFNlNl4ryZ5SUk-GVyqL_NkjSnuIyGcqdIYii37KZJKLgFZeu-yWfk2q9zCmuHaoZr36LKSjUWD2O99rZjcVSOYr8ZfOa9-n5VZG26cet6LfebLQyCMCVPusrZ7pNv-nmoMH9vJyHDisGVAFvdk5uiM2HsyKDcKat7J9N61-5k2KisLrRyhaXancxTJaSl7xiOq_rGdFJcCDGSw5Zqba2PdLstanD3tFCOi918u2s3gwL95JxqurpyOB77oMVrWgstBaWgKX17fcRObBRvKF1Pzq8W6y-9BuDZui23XvuQOfbxlw-7Tye6z-ZpdZ_VI_ZQGy38XLHtMZukxRN2ulTQNmd8NSTxVWf8lC-HeujNU7ZTlORIST6iJC8zrijJFSU5UZJ3lOSakpwoyW9RkveU5FDxlpJcUfIZW31erD5dGrrFhxE7gXVjkDUegPDcKAKI0HRNcPMCkAJiS5IuFVtoX0TgZRCYme97ZiIBjXALfB9wl5-z46Is0peMe7GIAH-I4iVDpTQDCLxAOD4IyFy8zZTNuz0O96qQS9hFOO5CDUpIoKBRHCIoUyY7JEKtjSotM0T6_G7q-w65EKU1bQoUaVlXoU1RpYKKgE7ZCwVpv5o2ZsH2zFf__uDX7MHwz3rDjm8OdfqWHVVJ_U5z9CcE68iU
link.rule.ids 315,782,786,27933,27934
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Powder+bed+3D-printing+of+highly+loaded+drug+delivery+devices+with+hydroxypropyl+cellulose+as+solid+binder&rft.jtitle=International+journal+of+pharmaceutics&rft.au=Infanger%2C+Sophia&rft.au=Haemmerli%2C+Alexander&rft.au=Iliev%2C+Simona&rft.au=Baier%2C+Andrea&rft.date=2019-01-30&rft.pub=Elsevier+B.V&rft.issn=0378-5173&rft.eissn=1873-3476&rft.volume=555&rft.spage=198&rft.epage=206&rft_id=info:doi/10.1016%2Fj.ijpharm.2018.11.048&rft.externalDocID=S037851731830872X
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0378-5173&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0378-5173&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0378-5173&client=summon